Certain Centrifuge Utility Platform and Falling Film Evaporator Systems and Components Thereof; Commission Decision Terminating One Respondent Based on Settlement; Issuing an Exclusion Order and Cease and Desist Orders; Terminating the Investigation, 18586-18588 [2023-06450]
Download as PDF
18586
Federal Register / Vol. 88, No. 60 / Wednesday, March 29, 2023 / Notices
2. Any lineal descendant, Indian
Tribe, or Native Hawaiian organization
not identified in this notice who shows,
by a preponderance of the evidence, that
the requestor is a lineal descendant or
a culturally affiliated Indian Tribe or
Native Hawaiian organization.
Repatriation of the human remains in
this notice to a requestor may occur on
or after April 28, 2023. If competing
requests for repatriation are received,
SMNH must determine the most
appropriate requestor prior to
repatriation. Requests for joint
repatriation of the human remains are
considered a single request and not
competing requests. SMNH is
responsible for sending a copy of this
notice to the Indian Tribe identified in
this notice.
Authority: Native American Graves
Protection and Repatriation Act, 25
U.S.C. 3003, and the implementing
regulations, 43 CFR 10.9, 10.10, and
10.14.
Dated: March 22, 2023.
Melanie O’Brien,
Manager, National NAGPRA Program.
BILLING CODE 7020–02–P
INTERNATIONAL TRADE
COMMISSION
[Investigation No. 337–TA–1311]
Certain Centrifuge Utility Platform and
Falling Film Evaporator Systems and
Components Thereof; Commission
Decision Terminating One Respondent
Based on Settlement; Issuing an
Exclusion Order and Cease and Desist
Orders; Terminating the Investigation
Notice is hereby given that
the U.S. International Trade
Commission (‘‘Commission’’) has
determined to terminate one of the
seven defaulting respondents from the
investigation on the basis of settlement.
The Commission has also determined to
issue a limited exclusion order (‘‘LEO’’)
barring entry of certain centrifuge utility
platform and falling film evaporator
systems and components thereof that
are imported by or on behalf of the six
remaining defaulting respondents. The
Commission has further determined to
issue cease and desist orders (‘‘CDOs’’)
as to three of the six remaining
defaulting respondents. The
investigation is terminated.
FOR FURTHER INFORMATION CONTACT:
Sidney A. Rosenzweig, Esq., Office of
the General Counsel, U.S. International
Trade Commission, 500 E Street SW,
Washington, DC 20436, telephone (202)
708–2532. Copies of non-confidential
documents filed in connection with this
investigation may be viewed on the
Commission’s electronic docket (EDIS)
at https://edis.usitc.gov. For help
accessing EDIS, please email
EDIS3Help@usitc.gov. General
information concerning the Commission
may also be obtained by accessing its
internet server at https://www.usitc.gov.
Hearing-impaired persons are advised
that information on this matter can be
obtained by contacting the
SUMMARY:
INTERNATIONAL TRADE
COMMISSION
[Investigation Nos. 731–TA–313–314, 317,
and 379 (Fifth Review)]
Brass Sheet and Strip From France,
Germany, Italy, and Japan
Determinations
On the basis of the record 1 developed
in the subject five-year reviews, the
United States International Trade
Commission (‘‘Commission’’)
determines, pursuant to the Tariff Act of
1930 (‘‘the Act’’), that revocation of the
antidumping duty orders on brass sheet
and strip from France, Germany, Italy,
and Japan would be likely to lead to
continuation or recurrence of material
injury to an industry in the United
States within a reasonably foreseeable
time.
Background
ddrumheller on DSK120RN23PROD with NOTICES1
[FR Doc. 2023–06535 Filed 3–28–23; 8:45 am]
U.S. International Trade
Commission.
ACTION: Notice.
BILLING CODE 4312–52–P
The Commission instituted these
reviews on September 1, 2022 (87 FR
53785) and determined on December 6,
2022 that it would conduct expedited
reviews (88 FR 10380).
The Commission made these
determinations pursuant to section
751(c) of the Act (19 U.S.C. 1675(c)). It
1 The record is defined in § 207.2(f) of the
Commission’s Rules of Practice and Procedure (19
CFR 207.2(f)).
19:20 Mar 28, 2023
By order of the Commission.
Issued: March 24, 2023.
Lisa Barton,
Secretary to the Commission.
AGENCY:
[FR Doc. 2023–06478 Filed 3–28–23; 8:45 am]
VerDate Sep<11>2014
completed and filed its determinations
in these reviews on March 24, 2023. The
views of the Commission are contained
in USITC Publication 5414 (March
2023), entitled Brass Sheet and Strip
from France, Germany, Italy, and Japan:
Investigation Nos. 731–TA–313–314,
317, and 379 (Fifth Review).
Jkt 259001
PO 00000
Frm 00075
Fmt 4703
Sfmt 4703
Commission’s TDD terminal on (202)
205–1810.
SUPPLEMENTARY INFORMATION: The
Commission instituted this investigation
on May 4, 2022. 87 FR 26372 (May 4,
2022). The complaint, as supplemented,
alleged violations of section 337 of the
Tariff Act of 1930, as amended, 19
U.S.C. 1337, in the importation into the
United States, the sale for importation,
or the sale within the United States after
importation of certain centrifuge utility
platform and falling film evaporator
systems and components thereof by
reason of infringement of claims 1, 10,
and 14 of U.S. Patent No. 10,814,338
(‘‘the ’338 patent’’); claims 1, 10, and 18
of U.S. Patent No. 11,014,098 (‘‘the ’098
patent’’); and claims 1, 9, and 19 of U.S.
Patent No. 10,899,728 (‘‘the ’728
patent’’). Id. The complaint further
alleged that a domestic industry exists.
Id. The Commission’s notice of
investigation named fifteen
respondents, including Ambiopharm,
Inc. of Beech Island, South Carolina
(‘‘Ambiopharm’’); RI Hemp Farms, LLC
of West Greenwich, Rhode Island (‘‘RI
Hemp Farms’’); Henan Lanphan
Industry Co., Ltd. of Zhengzhou, China
(‘‘Henan Lanphan’’); Toption Instrument
Co., Ltd. of Xi’an, China (‘‘Toption’’);
Ezhydro of Sacramento, California
(‘‘Ezhydro’’); Shanghai Yuanhuai
Industries Co., Ltd. of Shanghai City,
China (‘‘Shanghai Yuanhuai’’);
Zhangjiagang Chunk d/b/a Charme
Trading Corp. of Suzhou Shi, China
(‘‘Charme’’); Calpha Industries, Inc. of
Laguna Hills, California (‘‘Calpha’’);
Comerg, LLC of Phoenix, Arizona
(‘‘Comerg’’); HX Labs, LLC of Albany,
Oregon (‘‘HX’’); Idea Makers, LLC of
Lake City, Utah (‘‘Idea Makers’’); Lab1st
Scientific and Industrial Equipment,
Inc. of Shanghai, China (‘‘Lab1st’’);
Miracle Education Distributors, Inc. of
Cathedral City, California (‘‘Miracle’’);
Mountain Pure, LLC of Vineyeard, Utah
(‘‘Mountain Pure’’); and Redford
Management of Los Angeles, California
(‘‘Redford’’). Id. at 26373. The Office of
Unfair Import Investigations (‘‘OUII’’) is
also participating in the investigation.
Id.
On August 4, 2022, the Commission
determined not to review an initial
determination (Order No. 15) finding
Ambiopharm and RI Hemp Farms in
default. Order No. 15 (July 7, 2022),
unreviewed by Comm’n Notice (Aug. 4,
2022). On August 4, 2022, the
Commission determined not to review
an initial determination (Order No. 21)
finding Henan Lanphan and Toption in
default. Order No. 21 (July 19, 2022),
unreviewed by Comm’n Notice (Aug. 5,
2022). Also on August 4, 2022, the
E:\FR\FM\29MRN1.SGM
29MRN1
ddrumheller on DSK120RN23PROD with NOTICES1
Federal Register / Vol. 88, No. 60 / Wednesday, March 29, 2023 / Notices
Commission determined not to review
an initial determination (Order No. 22)
finding Ezhydro in default. Order No. 22
(July 20, 2022), unreviewed by Comm’n
Notice (Aug. 5, 2022). On August 29,
2022, the Commission determined not
to review an initial determination
(Order No. 26) finding Shanghai
Yuanhuai and Charme in default. Order
No. 26 (July 29, 2022), unreviewed by
Comm’n Notice (Aug. 29, 2022). All
other respondents named in the notice
of investigation have been terminated
from the investigation. Respondents
Mountain Pure, Rexford, Comerg and
Miracle were terminated from the
investigation based on complaint
withdrawal. Order No. 7 (May 25, 2022),
unreviewed by Comm’n Notice (June 21,
2022); Order No. 20 (July 19, 2022),
unreviewed by Comm’n Notice (Aug. 4,
2022); Order No. 24 (July 25, 2022),
unreviewed by Comm’n Notice (Aug. 4,
2022); Order No. 25 (July 28, 2022),
unreviewed by Comm’n Notice (Aug. 29,
2022). Respondents HX, Calpha, Lab1st,
and Idea Makers were terminated based
on settlement. See Order No. 14 (July 5,
2022), unreviewed by Comm’n Notice
(Aug. 2, 2022); Order No. 18 (July 15,
2022), unreviewed by Comm’n Notice
(Aug. 4, 2022); Order No. 23 (July 25,
2022), unreviewed by Comm’n Notice
(Aug. 4, 2022).
On September 1, 2022, complainant
Apeks, LLC (‘‘Apeks’’) filed a ‘‘Written
Submission on Remedy, the Public
Interest and Bonding.’’ On September
20, 2022, Apeks filed a motion to
terminate the investigation as to
defaulting respondent Toption based on
settlement. Apeks filed a corrected
version of that motion thereafter on
September 23, 2022. On the same day,
OUII filed a response supporting Apeks’
motion to terminate Toption from the
investigation. Apeks’ motion is
currently pending before the
Commission.
On September 30, 2022, the
Commission requested written
submissions from the parties to the
investigation, interested government
agencies, and any other interested
parties on the issues of remedy, the
public interest, and bonding. Notice, 87
FR 60414 (Oct. 5, 2022). On October 14,
2022, Apeks and OUII each filed an
opening submission on these issues.1
On October 21, 2022, OUII filed a reply
1 Compl’t Apeks’ Written Submission on Remedy,
the Public Interest and Bonding (Oct. 14, 2022)
(‘‘Apeks Opening Submission’’); Brief of the Office
of Unfair Import Investigations on Remedy, the
Public Interest, and Bonding (Oct. 14, 2022) (‘‘OUII
Opening Submission’’).
VerDate Sep<11>2014
19:20 Mar 28, 2023
Jkt 259001
to Apeks’ opening submission.2 No
other submissions were received.
Having examined the record of the
investigation, including Apeks’
corrected motion to terminate the
investigation as to Toption because of
settlement, and the response thereto, the
Commission has determined to grant the
motion to terminate the investigation as
to Toption on the basis of settlement.
Accordingly, for the purpose of
determining remedy, the public interest,
and bonding, six defaulting respondents
remain: Ambiopharm, RI Hemp Farms,
Henan Lanphan, Ezhydro, Shanghai
Yuanhuai, and Charme (collectively, the
‘‘Defaulting Respondents’’).
When the conditions in section
337(g)(1)(A)–(g)(1)(E) (19 U.S.C.
1337(g)(1)(A)–(g)(1)(E)) have been
satisfied, section 337(g)(1) and
Commission Rule 210.16(c) (19 CFR
210.16(c)) direct the Commission, upon
request, to issue a limited exclusion
order or a cease and desist order or both
against a respondent found in default,
based on the allegations regarding a
violation of section 337 in the
Complaint, which are presumed to be
true, unless after consideration of the
public interest factors in section
337(g)(1), it finds that such relief should
not issue.
Having examined the record of this
investigation, including the submissions
in response to the Commission’s notice,
the Commission has determined
pursuant to subsection 337(g)(1) that the
appropriate remedy in this investigation
is an LEO prohibiting the unlicensed
entry of certain centrifuge utility
platform and falling film evaporator
systems and components thereof that
infringe one or more of claims 1, 10, and
14 of the ’338 patent and claims 1, 10,
and 18 of the ’098 patent, and that are
imported by or on behalf of
Ambiopharm, RI Hemp Farms, Shanghai
Yuanhui, or Charme. In addition, and
consistent with the infringement
allegations in the complaint, the LEO
prohibits the unlicensed entry of certain
centrifuge utility platform and falling
film evaporator systems and
components thereof that infringe one or
more of claims 1, 9, and 19 of the ’728
patent, and that are imported by Henan
Lanphan, EZhydro, or Shanghai
Yuanhuai. The Commission has further
determined to issue cease and desist
orders directed to the domestic
respondents, Ambiopharm, RI Hemp
Farms, and Ezydro. Because there is no
support in the record for commercially
2 Reply Brief of the Office of Unfair Import
Investigations on Remedy, the Public Interest, and
Bonding (Oct. 21, 2022) (‘‘OUII Reply
Submission’’).
PO 00000
Frm 00076
Fmt 4703
Sfmt 4703
18587
significant U.S. inventories and/or
significant commercial business
operations in the United States as to the
foreign respondents, Henan Lanphan,
Shanghai Yuanhai, or Charme, the
Commission, consistent with its
customary practice, declines to issue
cease and desist orders as to them.3 See
Electric Skin Care Devices, Comm’n Op.
at 29–30. The Commission finds that the
public interest factors enumerated in
subsection 337(g)(1) do not preclude the
issuance of the LEO or the CDOs.
As to bonding, Apeks argues that 19
U.S.C. 1337(j)(3) ‘‘does not authorize the
Commission to permit defaulted
respondents subject to an exclusion
order under’’ 19 U.S.C. 1337(g)(1) ‘‘to
import infringing products under bond
during the Presidential review period.’’
Apeks Opening Submission at 10. In the
alternative, Apeks asserts that bond
during the period of Presidential review
should be set at one hundred percent
(100%) of the entered value of the
imported articles that are the subject of
the LEO. Id.
In response, OUII asserts that the
Commission has the discretion to
impose a bond during Presidential
review. OUII Reply Submission at 2.
OUII further notes that it is customary
for the Commission to include bonding
provisions even as to defaulting
respondents. Id. at 2–3.
Having reviewed the text and
legislative history of section 337,4 the
Commission notes that its consistent
practice, including before and after the
1994 amendments to section 337, has
been to impose a bond during the
Presidential review period, including as
to defaulting parties. E.g., Certain
Toothbrushes and the Packaging
Thereof, Inv. No. 337–TA–391, Comm’n
Notice, 62 FR 54855 (Oct. 22, 1997);
Certain Electrical Connectors and
Products Containing Same, Inv. No.
337–TA–374, Comm’n Notice, 61 FR
21208 (May 9, 1996); Certain
Woodworking Accessories, Inv. No.
337–TA–333, Comm’n Notice, 58 FR
4718 (Jan. 15, 1993); Certain Soft Drinks
and Their Containers, Inv. No. 337–TA–
321, Comm’n Notice, 57 FR 304 (Jan. 3,
1992); Certain Key Blanks for Keys of
3 Commissioners Karpel and Schmidtlein would
have issued cease and desist orders as to the foreign
defaulting respondents, regardless of domestic
business operations or inventories, for the reasons
explained in, for example, Certain Vaporizer
Cartridges and Components Thereof, Inv. No. 337–
TA–1211, Comm’n Op. at 13–14 (Mar. 1, 2022).
4 See, e.g., Omnibus Trade and Competitiveness
Act of 1988, Public Law 100–418, 1341–1342, 102
Stat. 1107, 1211–16 (1988); H.R. Rep. No. 100–40
(Part I), at 160–62 (1987); S. Rep. No. 100–71, at 132
(1987); Uruguay Round Agreements Act, Public
Law 103–465, 321, 108 Stat. 4809, 4943–44 (1994);
S. Rep. 103–412, at 120 (1994).
E:\FR\FM\29MRN1.SGM
29MRN1
18588
Federal Register / Vol. 88, No. 60 / Wednesday, March 29, 2023 / Notices
High Security Cylinder Locks, No. 337–
TA–308, Comm’n Notice, 55 FR 35372
(Aug. 29, 1990). The Commission finds
no indication that Congress intended to
constrain the Commission’s authority to
impose a bond during the Presidential
review period as to defaulting
respondents nor any statutory constraint
that would override the Commission’s
long-standing practice. Further, the
Commission notes that it has ‘‘broad
discretion in selecting the form, scope
and extent of the remedy.’’ Viscofan,
S.A. v. United States Int’l Trade
Comm’n, 787 F.2d 544, 548 (Fed. Cir.
1986). Accordingly, the Commission
finds that it is within its remedial
discretion to allow bonding during the
Presidential review period as to the
Defaulting Respondents. Accordingly, in
this investigation, the Commission has
determined that the bond during the
period of Presidential review pursuant
to section 337(j) (19 U.S.C. 1337(j)) shall
be in the amount of one hundred
percent (100%) of the entered value of
the subject articles as requested by
Apeks.5 The investigation is terminated.
The Commission vote for this
determination took place on March 23,
2023.
The authority for the Commission’s
determination is contained in section
337 of the Tariff Act of 1930, as
amended (19 U.S.C. 1337), and in Part
210 of the Commission’s Rules of
Practice and Procedure (19 CFR part
210).
While temporary remote operating
procedures are in place in response to
COVID–19, the Office of the Secretary is
not able to serve parties that have not
retained counsel or otherwise provided
a point of contact for electronic service.
Accordingly, pursuant to Commission
Rules 201.16(a) and 210.7(a)(1) (19 CFR
201.16(a), 210.7(a)(1)), the Commission
orders that the Complainant complete
service for any party/parties without a
method of electronic service noted on
the attached Certificate of Service and
shall file proof of service on the
Electronic Document Information
System (EDIS).
By order of the Commission.
Issued: March 23, 2023.
Lisa Barton,
Secretary to the Commission.
[FR Doc. 2023–06450 Filed 3–28–23; 8:45 am]
BILLING CODE 7020–02–P
DEPARTMENT OF JUSTICE
[OMB Number 1110–0076]
Agency Information Collection
Activities; Proposed eCollection
eComments Requested; Revision of a
Currently Approved Collection; for the
Law Enforcement Executive
Development Seminar (LEEDS), FBI
National Academy and National
Executive Institute Program
Questionnaires
Federal Bureau of
Investigation, Department of Justice.
ACTION: 60-Day notice.
AGENCY:
The Department of Justice,
Federal Bureau of Investigation (FBI),
Training Division’s Curriculum
Management Section (CMS), is
submitting the following information
collection request to the Office of
Management and Budget (OMB) for
review and approval in accordance with
the Paperwork Reduction Act of 1995.
DATES: The Department of Justice
encourages public comment and will
accept input until May 30, 2023.
FOR FURTHER INFORMATION CONTACT:
Written comments/or suggestions
regarding the items contained in this
notice, especially the estimated public
burden associated response time, should
be directed to U.S. Department of
Justice, Federal Bureau of Investigation,
contact Denielle Johnson, Unit Chief,
Evaluation and Certification Unit,
Training Division, FBI Academy, email
address djjohnson2@fbi.gov, and
telephone number 703–632–1000.
Written comments and/or suggestions
can also be sent to the Office of
Management and Budget, Office of
Information and Regulatory Affairs,
SUMMARY:
ddrumheller on DSK120RN23PROD with NOTICES1
5 Commissioner
Schmidtlein agrees with Apeks’
argument that section 337 does not authorize the
Commission to permit the Defaulting Respondents
to import infringing products under bond during
the Presidential review period. To her knowledge,
this is the first time this issue has been raised by
a party in an investigation. She observes that the
bonding provision of the statute, section 337(j)(3),
only authorizes importation during the Presidential
review period under bond for ‘‘articles directed to
be excluded from entry under subsection (d) or
subject to a cease and desist order under subsection
(f).’’ The Defaulting Respondents are subject to
remedial relief under subsection (g) not subsections
(d) or (f). Subsection (g) governs remedial relief for
respondents that do not participate in 337
investigations. By the plain language of section
337(j)(3), the ability to import under bond is
unavailable for default remedies issued under
subsection (g). Commissioner Schmidtlein finds
nothing in the legislative history that speaks to this
issue and even if it did it could not be used to
change the plain language of the statute. See In re
City of Houston, 731 F.3d 1326, 1333 (Fed. Cir.
2013) (legislative history cannot be used to
contravene the plain language of statute). She also
does not agree that the discretion retained by the
Commission when it comes to selecting the form,
scope and extent of the remedy permits it to act
contrary to the plain language of the statute. She
would therefore grant Apeks’ request and not
authorize the Defaulting Respondents to import
infringing products under bond during the
Presidential review period.
VerDate Sep<11>2014
19:20 Mar 28, 2023
Jkt 259001
PO 00000
Frm 00077
Fmt 4703
Sfmt 4703
Attention Department of Justice Desk
Officer, Washington, DC 20503 or sent
to OIRA_submission@omb.eop.gov.
SUPPLEMENTARY INFORMATION: Written
comments and suggestions from the
public and affected agencies concerning
the proposed collection of information
are encouraged. Your comments should
address one or more of the following
four points:
➢ Evaluate whether the proposed
collection of information is necessary
for the proper performance of the
functions of the Federal Bureau of
Investigation, Training Division,
including whether the information will
have practical utility;
➢ Evaluate the accuracy of the
agency’s estimate of the burden of the
proposed collection of information,
including the validity of the
methodology and assumptions used;
➢ Evaluate whether and if so how the
quality, utility, and clarity of the
information to be collected can be
enhanced; and
➢ Minimize the burden of the
collection of information on those who
are to respond, including through the
use of appropriate automated,
electronic, mechanical, or other
technological collection techniques or
other forms of information technology,
e.g., permitting electronic submission of
responses.
Overview of This Information
Collection
1. Type of Information Collection:
Revision of a currently approved
collection.
2. The Title of the Form/Collection:
FBI Education and Training for Law
Enforcement Officers.
3. The agency form number, if any,
and the applicable component of the
Department sponsoring the collection:
‘‘There is no agency form number for
this collection.’’ The applicable
component within the Department of
Justice is the Training Division.
4. Affected public who will be asked
or required to respond, as well as a brief
abstract: State/Local and Federal law
enforcement. This collection will gather
feedback from graduates to determine if
the training received from the has made
an impact on their agency.
5. An estimate of the total number of
respondents and the amount of time
estimated for an average respondent to
respond: 8,250 respondents with an
approximate 10 minute burden.
6. An estimate of the total public
burden (in hours) associated with the
collection: approximately 1,375 hours.
If additional information is required
contact: John Carlson, Assistant
Director, United States Department of
E:\FR\FM\29MRN1.SGM
29MRN1
Agencies
[Federal Register Volume 88, Number 60 (Wednesday, March 29, 2023)]
[Notices]
[Pages 18586-18588]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2023-06450]
-----------------------------------------------------------------------
INTERNATIONAL TRADE COMMISSION
[Investigation No. 337-TA-1311]
Certain Centrifuge Utility Platform and Falling Film Evaporator
Systems and Components Thereof; Commission Decision Terminating One
Respondent Based on Settlement; Issuing an Exclusion Order and Cease
and Desist Orders; Terminating the Investigation
AGENCY: U.S. International Trade Commission.
ACTION: Notice.
-----------------------------------------------------------------------
SUMMARY: Notice is hereby given that the U.S. International Trade
Commission (``Commission'') has determined to terminate one of the
seven defaulting respondents from the investigation on the basis of
settlement. The Commission has also determined to issue a limited
exclusion order (``LEO'') barring entry of certain centrifuge utility
platform and falling film evaporator systems and components thereof
that are imported by or on behalf of the six remaining defaulting
respondents. The Commission has further determined to issue cease and
desist orders (``CDOs'') as to three of the six remaining defaulting
respondents. The investigation is terminated.
FOR FURTHER INFORMATION CONTACT: Sidney A. Rosenzweig, Esq., Office of
the General Counsel, U.S. International Trade Commission, 500 E Street
SW, Washington, DC 20436, telephone (202) 708-2532. Copies of non-
confidential documents filed in connection with this investigation may
be viewed on the Commission's electronic docket (EDIS) at https://edis.usitc.gov. For help accessing EDIS, please email
[email protected]. General information concerning the Commission may
also be obtained by accessing its internet server at https://www.usitc.gov. Hearing-impaired persons are advised that information on
this matter can be obtained by contacting the Commission's TDD terminal
on (202) 205-1810.
SUPPLEMENTARY INFORMATION: The Commission instituted this investigation
on May 4, 2022. 87 FR 26372 (May 4, 2022). The complaint, as
supplemented, alleged violations of section 337 of the Tariff Act of
1930, as amended, 19 U.S.C. 1337, in the importation into the United
States, the sale for importation, or the sale within the United States
after importation of certain centrifuge utility platform and falling
film evaporator systems and components thereof by reason of
infringement of claims 1, 10, and 14 of U.S. Patent No. 10,814,338
(``the '338 patent''); claims 1, 10, and 18 of U.S. Patent No.
11,014,098 (``the '098 patent''); and claims 1, 9, and 19 of U.S.
Patent No. 10,899,728 (``the '728 patent''). Id. The complaint further
alleged that a domestic industry exists. Id. The Commission's notice of
investigation named fifteen respondents, including Ambiopharm, Inc. of
Beech Island, South Carolina (``Ambiopharm''); RI Hemp Farms, LLC of
West Greenwich, Rhode Island (``RI Hemp Farms''); Henan Lanphan
Industry Co., Ltd. of Zhengzhou, China (``Henan Lanphan''); Toption
Instrument Co., Ltd. of Xi'an, China (``Toption''); Ezhydro of
Sacramento, California (``Ezhydro''); Shanghai Yuanhuai Industries Co.,
Ltd. of Shanghai City, China (``Shanghai Yuanhuai''); Zhangjiagang
Chunk d/b/a Charme Trading Corp. of Suzhou Shi, China (``Charme'');
Calpha Industries, Inc. of Laguna Hills, California (``Calpha'');
Comerg, LLC of Phoenix, Arizona (``Comerg''); HX Labs, LLC of Albany,
Oregon (``HX''); Idea Makers, LLC of Lake City, Utah (``Idea Makers'');
Lab1st Scientific and Industrial Equipment, Inc. of Shanghai, China
(``Lab1st''); Miracle Education Distributors, Inc. of Cathedral City,
California (``Miracle''); Mountain Pure, LLC of Vineyeard, Utah
(``Mountain Pure''); and Redford Management of Los Angeles, California
(``Redford''). Id. at 26373. The Office of Unfair Import Investigations
(``OUII'') is also participating in the investigation. Id.
On August 4, 2022, the Commission determined not to review an
initial determination (Order No. 15) finding Ambiopharm and RI Hemp
Farms in default. Order No. 15 (July 7, 2022), unreviewed by Comm'n
Notice (Aug. 4, 2022). On August 4, 2022, the Commission determined not
to review an initial determination (Order No. 21) finding Henan Lanphan
and Toption in default. Order No. 21 (July 19, 2022), unreviewed by
Comm'n Notice (Aug. 5, 2022). Also on August 4, 2022, the
[[Page 18587]]
Commission determined not to review an initial determination (Order No.
22) finding Ezhydro in default. Order No. 22 (July 20, 2022),
unreviewed by Comm'n Notice (Aug. 5, 2022). On August 29, 2022, the
Commission determined not to review an initial determination (Order No.
26) finding Shanghai Yuanhuai and Charme in default. Order No. 26 (July
29, 2022), unreviewed by Comm'n Notice (Aug. 29, 2022). All other
respondents named in the notice of investigation have been terminated
from the investigation. Respondents Mountain Pure, Rexford, Comerg and
Miracle were terminated from the investigation based on complaint
withdrawal. Order No. 7 (May 25, 2022), unreviewed by Comm'n Notice
(June 21, 2022); Order No. 20 (July 19, 2022), unreviewed by Comm'n
Notice (Aug. 4, 2022); Order No. 24 (July 25, 2022), unreviewed by
Comm'n Notice (Aug. 4, 2022); Order No. 25 (July 28, 2022), unreviewed
by Comm'n Notice (Aug. 29, 2022). Respondents HX, Calpha, Lab1st, and
Idea Makers were terminated based on settlement. See Order No. 14 (July
5, 2022), unreviewed by Comm'n Notice (Aug. 2, 2022); Order No. 18
(July 15, 2022), unreviewed by Comm'n Notice (Aug. 4, 2022); Order No.
23 (July 25, 2022), unreviewed by Comm'n Notice (Aug. 4, 2022).
On September 1, 2022, complainant Apeks, LLC (``Apeks'') filed a
``Written Submission on Remedy, the Public Interest and Bonding.'' On
September 20, 2022, Apeks filed a motion to terminate the investigation
as to defaulting respondent Toption based on settlement. Apeks filed a
corrected version of that motion thereafter on September 23, 2022. On
the same day, OUII filed a response supporting Apeks' motion to
terminate Toption from the investigation. Apeks' motion is currently
pending before the Commission.
On September 30, 2022, the Commission requested written submissions
from the parties to the investigation, interested government agencies,
and any other interested parties on the issues of remedy, the public
interest, and bonding. Notice, 87 FR 60414 (Oct. 5, 2022). On October
14, 2022, Apeks and OUII each filed an opening submission on these
issues.\1\ On October 21, 2022, OUII filed a reply to Apeks' opening
submission.\2\ No other submissions were received.
---------------------------------------------------------------------------
\1\ Compl't Apeks' Written Submission on Remedy, the Public
Interest and Bonding (Oct. 14, 2022) (``Apeks Opening Submission'');
Brief of the Office of Unfair Import Investigations on Remedy, the
Public Interest, and Bonding (Oct. 14, 2022) (``OUII Opening
Submission'').
\2\ Reply Brief of the Office of Unfair Import Investigations on
Remedy, the Public Interest, and Bonding (Oct. 21, 2022) (``OUII
Reply Submission'').
---------------------------------------------------------------------------
Having examined the record of the investigation, including Apeks'
corrected motion to terminate the investigation as to Toption because
of settlement, and the response thereto, the Commission has determined
to grant the motion to terminate the investigation as to Toption on the
basis of settlement. Accordingly, for the purpose of determining
remedy, the public interest, and bonding, six defaulting respondents
remain: Ambiopharm, RI Hemp Farms, Henan Lanphan, Ezhydro, Shanghai
Yuanhuai, and Charme (collectively, the ``Defaulting Respondents'').
When the conditions in section 337(g)(1)(A)-(g)(1)(E) (19 U.S.C.
1337(g)(1)(A)-(g)(1)(E)) have been satisfied, section 337(g)(1) and
Commission Rule 210.16(c) (19 CFR 210.16(c)) direct the Commission,
upon request, to issue a limited exclusion order or a cease and desist
order or both against a respondent found in default, based on the
allegations regarding a violation of section 337 in the Complaint,
which are presumed to be true, unless after consideration of the public
interest factors in section 337(g)(1), it finds that such relief should
not issue.
Having examined the record of this investigation, including the
submissions in response to the Commission's notice, the Commission has
determined pursuant to subsection 337(g)(1) that the appropriate remedy
in this investigation is an LEO prohibiting the unlicensed entry of
certain centrifuge utility platform and falling film evaporator systems
and components thereof that infringe one or more of claims 1, 10, and
14 of the '338 patent and claims 1, 10, and 18 of the '098 patent, and
that are imported by or on behalf of Ambiopharm, RI Hemp Farms,
Shanghai Yuanhui, or Charme. In addition, and consistent with the
infringement allegations in the complaint, the LEO prohibits the
unlicensed entry of certain centrifuge utility platform and falling
film evaporator systems and components thereof that infringe one or
more of claims 1, 9, and 19 of the '728 patent, and that are imported
by Henan Lanphan, EZhydro, or Shanghai Yuanhuai. The Commission has
further determined to issue cease and desist orders directed to the
domestic respondents, Ambiopharm, RI Hemp Farms, and Ezydro. Because
there is no support in the record for commercially significant U.S.
inventories and/or significant commercial business operations in the
United States as to the foreign respondents, Henan Lanphan, Shanghai
Yuanhai, or Charme, the Commission, consistent with its customary
practice, declines to issue cease and desist orders as to them.\3\ See
Electric Skin Care Devices, Comm'n Op. at 29-30. The Commission finds
that the public interest factors enumerated in subsection 337(g)(1) do
not preclude the issuance of the LEO or the CDOs.
---------------------------------------------------------------------------
\3\ Commissioners Karpel and Schmidtlein would have issued cease
and desist orders as to the foreign defaulting respondents,
regardless of domestic business operations or inventories, for the
reasons explained in, for example, Certain Vaporizer Cartridges and
Components Thereof, Inv. No. 337-TA-1211, Comm'n Op. at 13-14 (Mar.
1, 2022).
---------------------------------------------------------------------------
As to bonding, Apeks argues that 19 U.S.C. 1337(j)(3) ``does not
authorize the Commission to permit defaulted respondents subject to an
exclusion order under'' 19 U.S.C. 1337(g)(1) ``to import infringing
products under bond during the Presidential review period.'' Apeks
Opening Submission at 10. In the alternative, Apeks asserts that bond
during the period of Presidential review should be set at one hundred
percent (100%) of the entered value of the imported articles that are
the subject of the LEO. Id.
In response, OUII asserts that the Commission has the discretion to
impose a bond during Presidential review. OUII Reply Submission at 2.
OUII further notes that it is customary for the Commission to include
bonding provisions even as to defaulting respondents. Id. at 2-3.
Having reviewed the text and legislative history of section 337,\4\
the Commission notes that its consistent practice, including before and
after the 1994 amendments to section 337, has been to impose a bond
during the Presidential review period, including as to defaulting
parties. E.g., Certain Toothbrushes and the Packaging Thereof, Inv. No.
337-TA-391, Comm'n Notice, 62 FR 54855 (Oct. 22, 1997); Certain
Electrical Connectors and Products Containing Same, Inv. No. 337-TA-
374, Comm'n Notice, 61 FR 21208 (May 9, 1996); Certain Woodworking
Accessories, Inv. No. 337-TA-333, Comm'n Notice, 58 FR 4718 (Jan. 15,
1993); Certain Soft Drinks and Their Containers, Inv. No. 337-TA-321,
Comm'n Notice, 57 FR 304 (Jan. 3, 1992); Certain Key Blanks for Keys of
[[Page 18588]]
High Security Cylinder Locks, No. 337-TA-308, Comm'n Notice, 55 FR
35372 (Aug. 29, 1990). The Commission finds no indication that Congress
intended to constrain the Commission's authority to impose a bond
during the Presidential review period as to defaulting respondents nor
any statutory constraint that would override the Commission's long-
standing practice. Further, the Commission notes that it has ``broad
discretion in selecting the form, scope and extent of the remedy.''
Viscofan, S.A. v. United States Int'l Trade Comm'n, 787 F.2d 544, 548
(Fed. Cir. 1986). Accordingly, the Commission finds that it is within
its remedial discretion to allow bonding during the Presidential review
period as to the Defaulting Respondents. Accordingly, in this
investigation, the Commission has determined that the bond during the
period of Presidential review pursuant to section 337(j) (19 U.S.C.
1337(j)) shall be in the amount of one hundred percent (100%) of the
entered value of the subject articles as requested by Apeks.\5\ The
investigation is terminated.
---------------------------------------------------------------------------
\4\ See, e.g., Omnibus Trade and Competitiveness Act of 1988,
Public Law 100-418, 1341-1342, 102 Stat. 1107, 1211-16 (1988); H.R.
Rep. No. 100-40 (Part I), at 160-62 (1987); S. Rep. No. 100-71, at
132 (1987); Uruguay Round Agreements Act, Public Law 103-465, 321,
108 Stat. 4809, 4943-44 (1994); S. Rep. 103-412, at 120 (1994).
\5\ Commissioner Schmidtlein agrees with Apeks' argument that
section 337 does not authorize the Commission to permit the
Defaulting Respondents to import infringing products under bond
during the Presidential review period. To her knowledge, this is the
first time this issue has been raised by a party in an
investigation. She observes that the bonding provision of the
statute, section 337(j)(3), only authorizes importation during the
Presidential review period under bond for ``articles directed to be
excluded from entry under subsection (d) or subject to a cease and
desist order under subsection (f).'' The Defaulting Respondents are
subject to remedial relief under subsection (g) not subsections (d)
or (f). Subsection (g) governs remedial relief for respondents that
do not participate in 337 investigations. By the plain language of
section 337(j)(3), the ability to import under bond is unavailable
for default remedies issued under subsection (g). Commissioner
Schmidtlein finds nothing in the legislative history that speaks to
this issue and even if it did it could not be used to change the
plain language of the statute. See In re City of Houston, 731 F.3d
1326, 1333 (Fed. Cir. 2013) (legislative history cannot be used to
contravene the plain language of statute). She also does not agree
that the discretion retained by the Commission when it comes to
selecting the form, scope and extent of the remedy permits it to act
contrary to the plain language of the statute. She would therefore
grant Apeks' request and not authorize the Defaulting Respondents to
import infringing products under bond during the Presidential review
period.
---------------------------------------------------------------------------
The Commission vote for this determination took place on March 23,
2023.
The authority for the Commission's determination is contained in
section 337 of the Tariff Act of 1930, as amended (19 U.S.C. 1337), and
in Part 210 of the Commission's Rules of Practice and Procedure (19 CFR
part 210).
While temporary remote operating procedures are in place in
response to COVID-19, the Office of the Secretary is not able to serve
parties that have not retained counsel or otherwise provided a point of
contact for electronic service. Accordingly, pursuant to Commission
Rules 201.16(a) and 210.7(a)(1) (19 CFR 201.16(a), 210.7(a)(1)), the
Commission orders that the Complainant complete service for any party/
parties without a method of electronic service noted on the attached
Certificate of Service and shall file proof of service on the
Electronic Document Information System (EDIS).
By order of the Commission.
Issued: March 23, 2023.
Lisa Barton,
Secretary to the Commission.
[FR Doc. 2023-06450 Filed 3-28-23; 8:45 am]
BILLING CODE 7020-02-P